Point72 Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-18
| Closed | -$364 | – | 1740 |
|
2023
Q3 | $364 | Buy |
+18
| New | +$364 | ﹤0.01% | 1691 |
|
2023
Q1 | – | Sell |
-132,774
| Closed | -$6.77M | – | 1858 |
|
2022
Q4 | $6.77M | Buy |
132,774
+132,541
| +56,885% | +$6.76M | 0.02% | 584 |
|
2022
Q3 | $19K | Buy |
+233
| New | +$19K | ﹤0.01% | 963 |
|
2020
Q4 | – | Sell |
-23,315
| Closed | -$5.11M | – | 974 |
|
2020
Q3 | $5.11M | Buy |
+23,315
| New | +$5.11M | 0.03% | 511 |
|
2019
Q3 | – | Sell |
-173,088
| Closed | -$15.6M | – | 1243 |
|
2019
Q2 | $15.6M | Buy |
+173,088
| New | +$15.6M | 0.08% | 264 |
|
2019
Q1 | – | Sell |
-102,781
| Closed | -$14.4M | – | 1010 |
|
2018
Q4 | $14.4M | Buy |
102,781
+46,081
| +81% | +$6.48M | 0.07% | 289 |
|
2018
Q3 | $14.5M | Sell |
56,700
-39,446
| -41% | -$10.1M | 0.06% | 288 |
|
2018
Q2 | $24.5M | Sell |
96,146
-34,422
| -26% | -$8.77M | 0.1% | 198 |
|
2018
Q1 | $26.3M | Sell |
130,568
-92,898
| -42% | -$18.7M | 0.11% | 197 |
|
2017
Q4 | $32.2M | Buy |
+223,466
| New | +$32.2M | 0.14% | 161 |
|
2014
Q4 | – | Sell |
-2,627
| Closed | -$1.38M | – | 705 |
|
2014
Q3 | $1.38M | Buy |
2,627
+2,094
| +393% | +$1.1M | 0.01% | 487 |
|
2014
Q2 | $372K | Buy |
+533
| New | +$372K | ﹤0.01% | 608 |
|